Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Study

Area of Science:

• Urology
• Gastroenterology
• Radiology

Background:

• Sporadic reports suggest a link between bladder urothelial carcinoma and common bile duct (CBD) dilation.
• No comprehensive studies have investigated this association previously.
• This study addresses the gap by comparing CBD size in urothelial carcinoma patients and controls.

Purpose of the Study:

• To compare the common bile duct (CBD) diameter in patients diagnosed with urothelial carcinoma versus a matched control group.
• To investigate potential correlations between CBD size and tumor characteristics like recurrence and metastasis.

Main Methods:

• Retrospective case-control study involving 63 urothelial carcinoma patients and 63 matched controls.
• Data on demographics, clinical history, smoking, and opium use were extracted.
• An experienced radiologist measured CBD diameter using CT scans, blinded to study objectives.

Main Results:

• Mean CBD diameter was significantly larger in urothelial carcinoma patients (6.81±2.77 mm) compared to controls (5.40±1.43 mm; p=0.004).
• Patients with tumor recurrence (8.58±3.45 mm) or metastases (8.35±4.16 mm) had significantly larger CBD diameters.
• Tumor recurrence and abnormal C-reactive protein (CRP) were significant risk factors for abnormal CBD diameter.

Conclusions:

• Urothelial carcinoma patients exhibit larger CBD diameters than matched controls.
• Increased CBD dilation is associated with tumor recurrence, suggesting a potential link.
• Further large-scale prospective studies are needed to validate findings and explore mechanisms.